EET agonist prevents adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an increase in HO-1 levels

Prostaglandins and Other Lipid Mediators

Volumn 98, Issue 3-4, 2012, Pages 133-142

  Sodhi, Komal ^a   Puri, Nitin ^a   Inoue, Kazuyoshi ^a   Falck, John R ^c   Schwartzman, Michal L ^b   Abraham, Nader G ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adiponectin; Cytochrome P450; HO 1; Metabolic dysfunction; Obesity

Indexed keywords

2 [11 (NONYLOXY)UNDEC 8 ENAMIDO]SUCCINIC ACID; ADIPONECTIN; CYTOKINE; EPOXIDE; EPOXYICOSATRIENOIC ACID; FATTY ACID DERIVATIVE; HEME OXYGENASE 1; INTERLEUKIN 6; MESOPORPHYRIN; PROTEIN KINASE B; SIRTUIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BACH 1; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HOMEOSTASIS; LIPID DIET; NONHUMAN; OBESITY; OXIDATIVE STRESS; RAT; VASCULAR DISEASE;

ADIPONECTIN; ADIPOSITY; ANIMALS; ASPARTIC ACID; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BIOLOGICAL MARKERS; BODY WEIGHT; CYTOKINES; DIET, HIGH-FAT; EICOSANOIDS; ENDOTHELIUM, VASCULAR; FERRITINS; GLYCOGEN SYNTHASE KINASE 3; HEME OXYGENASE (DECYCLIZING); HOMEOSTASIS; INFLAMMATION MEDIATORS; INTRA-ABDOMINAL FAT; METALLOPORPHYRINS; MODELS, BIOLOGICAL; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; REPRESSOR PROTEINS;

EID: 84864427972     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2011.12.004     Document Type: Article

References (55)

1. W.B. Campbell, and J.R. Falck Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors Hypertension 49 2007 590 596
2. D.C. Zeldin Epoxygenase pathways of arachidonic acid metabolism J Biol Chem 276 2001 36059 36062
3. A. Karara, E. Dishman, J.R. Falck, and J.H. Capdevila Endogenous epoxyeicosatrienoyl-phospholipids. A novel class of cellular glycerolipids containing epoxidized arachidonate moieties J Biol Chem 266 1991 7561 7569
4. J.D. Imig Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases Am J Physiol Renal Physiol 289 2005 F496 F503
5. A.A. Spector, and A.W. Norris Action of epoxyeicosatrienoic acids on cellular function Am J Physiol Cell Physiol 292 2007 C996 C1012
6. R.J. Roman P-450 metabolites of arachidonic acid in the control of cardiovascular function Physiol Rev 82 2002 131 185
7. D.N. Muller, J. Theuer, and E. Shagdarsuren A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury Am J Pathol 164 2004 521 532
8. K. Sodhi, K. Inoue, and K. Gotlinger Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice J Pharmacol Exp Ther 331 2009 906 916
9. N.G. Abraham, and A. Kappas Pharmacological and clinical aspects of heme oxygenase Pharmacol Rev 60 2008 79 127
10. A.L. Kruger, S.J. Peterson, and M.L. Schwartzman Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects J Pharmacol Exp Ther 319 2006 1144 1152
11. A. L'Abbate, D. Neglia, and C. Vecoli Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats Am J Physiol Heart Circ Physiol 293 2007 H3532 H3541
12. J-I. Kaide, F. Zhang, and Y. Wei Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors J Clin Invest 107 2001 1163 1171
13. D. Sacerdoti, M. Bolognesi, and P.M. Di Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase Am J Physiol Heart Circ Physiol 291 2006 H1999 H2002
14. D. Sacerdoti, C. Colombrita, and P.M. Di 11,12-epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells Prostaglandins Other Lipid Mediat 82 2007 155 161
15. M. Li, D.H. Kim, and P.L. Tsenovoy Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance Diabetes 57 2008 1526 1535
16. N.M. Hamburg, C.J. McMackin, and A.L. Huang Physical inactivity rapidly induces insulin resistance and microvascular dysfunction in healthy volunteers Arterioscler Thromb Vasc Biol 27 2007 2650 2656
17. D.H. Kim, L. Vanella, and K. Inoue EET-agonist regulates human mesenchymal stem cells-derived adipocytes through activation of HO-1-pAKT signaling and a decrease in PPARgamma Stem Cells Dev 19 12 2010 1863 1873
18. + channels contribute to 11,12-epoxyeicosatrienoic acid analog mediated mesenteric arterial relaxation Prostaglandins Other Lipid Mediat 83 2007 50 61
19. + Channels Microcirculation 15 2008 137 150
20. S.A. Schreyer, D.L. Wilson, and R.C. LeBoeuf C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis Atherosclerosis 136 1998 17 24
21. R.S. Surwit, C.M. Kuhn, C. Cochrane, J.A. McCubbin, and M.N. Feinglos Diet-induced type II diabetes in C57BL/6J mice Diabetes 37 1988 1163 1167
22. S.J. Peterson, D.H. Kim, and M. Li The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice J Lipid Res 50 2009 1293 1304
23. F.T. Botros, M.L. Schwartzman, C.T. Stier Jr., A.I. Goodman, and N.G. Abraham Increase in heme oxygenase-1 levels ameliorates renovascular hypertension Kidney Int 68 2005 2745 2755
24. A.A. Elmarakby, and J.D. Imig Obesity is the major contributor to vascular dysfunction and inflammation in high fat diet hypertensive rats Clin Sci (Lond) 118 2010 291 301
25. S.F. Knight, J.E. Quigley, J. Yuan, S.S. Roy, A. Elmarakby, and J.D. Imig Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet Hypertension 51 2008 352 359
26. S.F. Knight, J. Yuan, S. Roy, and J.D. Imig Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension Am J Physiol Renal Physiol 298 2010 F86 F94
27. B.T. Larsen, D.D. Gutterman, and A. Sato Hydrogen peroxide inhibits cytochrome p450 epoxygenases: interaction between two endothelium-derived hyperpolarizing factors Circ Res 102 2008 59 67
28. J.D. Imig Eicosanoid regulation of the renal vasculature Am J Physiol Renal Physiol 279 2000 F965 F981
29. M.H. Wang, A. Smith, and Y. Zhou Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension Hypertension 42 2003 594 599
30. K. Zhao, G. Luo, S. Giannelli, and H.H. Szeto Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines Biochem Pharmacol 70 2005 1796 1806
31. L. Malaguarnera, S. Quan, M.R. Pilastro, N.G. Abraham, and A. Kappas Diminished heme oxygenase potentiates cell death: pyrrolidinedithiocarbamate mediates oxidative stress Exp Biol Med (Maywood) 228 2003 459 465
32. N.G. Abraham, and G. Drummond CD163-Mediated hemoglobin-heme uptake activates macrophage HO-1, providing an antiinflammatory function Circ Res 99 2006 911 914
33. N.G. Abraham, J. Cao, D. Sacerdoti, X. Li, and G. Drummond Heme oxygenase: the key to renal function regulation Am J Physiol Renal Physiol 297 2009 F1137 F1152
34. R. Kinobe, Y. Ji, and K. Nakatsu Peroxynitrite-mediated inactivation of heme oxygenases BMC Pharmacol 4 2004 26
35. A. Paine, B. Eiz-Vesper, R. Blasczyk, and S. Immenschuh Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential Biochem Pharmacol 80 2010 1895 1903
36. L. Vanella, D.H. Kim, and K. Sodhi Crosstalk between EET and HO-1 downregulates Bach1 and adipogenic marker expression in mesenchymal stem cell derived adipocytes Prostaglandins Other Lipid Mediat 96 2011 54 62
37. T. Kitamuro, K. Takahashi, and K. Ogawa Bach 1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells J Biol Chem 278 2003 9125 9133
38. J.F. Reichard, M.A. Sartor, and A. Puga BACH1 is a specific repressor of HMOX1 that is inactivated by arsenite J Biol Chem 283 2008 22363 22370
39. S. Qin, and P.B. Chock Implication of phosphatidylinositol 3-kinase membrane recruitment in hydrogen peroxide-induced activation of PI3K and Akt Biochemistry (Mosc) 42 2003 2995 3003
40. E.R. Gross, A.K. Hsu, and G.J. Gross Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts Circ Res 94 2004 960 966
41. K.R. Chaudhary, S.N. Batchu, and D. Das Role of B-type natriuretic peptide in epoxyeicosatrienoic acid-mediated improved post-ischaemic recovery of heart contractile function Cardiovasc Res 83 2009 362 370
42. E.E. Cable, O.S. Gildemeister, J.A. Pepe, R.W. Lambrecht, and H.L. Bonkovsky Mechanism of induction of heme oxygenase by metalloporphyrins in primary chick embryo liver cells: evidence against a stress-mediated response Mol Cell Biochem 169 1997 13 20
43. D.E. Stec, H.A. Drummond, and T. Vera Role of carbon monoxide in blood pressure regulation Hypertension 51 2008 597 604
44. A. Kravets, Z. Hu, T. Miralem, M.D. Torno, and M.D. Maines Biliverdin reductase, a novel regulator for induction of activating transcription factor-2 and heme oxygenase-1 J Biol Chem 279 2004 19916 19923
45. D.H. Kim, A.P. Burgess, and M. Li Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines, tumor necrosis factor-alpha and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells J Pharmacol Exp Ther 325 2008 833 840
46. E. Tomas, T.S. Tsao, and A.K. Saha Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation Proc Natl Acad Sci U S A 99 2002 16309 16313
47. K.R. Laderoute, K. Amin, and J.M. Calaoagan 5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments Mol Cell Biol 26 2006 5336 5347
48. F. Picard, M. Kurtev, and N. Chung Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma Nature 429 2004 771 776
49. M. Kawai, and C.J. Rosen PPARgamma: a circadian transcription factor in adipogenesis and osteogenesis Nat Rev Endocrinol 6 2010 629 636
50. J. Kaide, F. Zhang, and Y. Wei Vascular CO counterbalances the sensitizing influence of 20-HETE on agonist-induced vasoconstriction Hypertension 44 2004 210 216
51. B.T. Larsen, H. Miura, and O.A. Hatoum Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition Am J Physiol Heart Circ Physiol 290 2006 H491 H499
52. I.S. Wood, F.P. de Heredia, B. Wang, and P. Trayhurn Cellular hypoxia and adipose tissue dysfunction in obesity Proc Nutr Soc 68 2009 370 377
53. Z.V. Wang, and P.E. Scherer Adiponectin, cardiovascular function, and hypertension Hypertension 51 2008 8 14
54. N. Ouchi, H. Kobayashi, and S. Kihara Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells J Biol Chem 279 2004 1304 1309
55. G. Sambuceti, S. Morbelli, and L. Vanella Diabetes impairs the vascular recruitment of normal stem cells by oxidant damage; reversed by increases in pAMPK, heme oxygenase-1 and adiponectin Stem Cells 27 2009 399 407